Rainbow BioSciences, LLC Targets Companion Diagnostics Opportunities in Booming $232 Billion Personalized Medicine Market

NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow Coral Corp.’s (OTCBB: RBCC) biotech subsidiary, Rainbow BioSciences, seeks out potentially lucrative new opportunities in the $232 billion personalized medicine market, the company announced today that it will target new innovations in the growing field of companion diagnostics. The personalized medicine market in the U.S. is ripe for expansion, with PricewaterhouseCoopers predicting that the sector could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com.